Analyst Downgrades – NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) Stock Gets Downgraded By Royal Bank of Canada from Outperform ➝ Sector Perform to

ME Staff
-
0

Analyst Ratings For NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)

Today, NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) stock was downgraded by Royal Bank of Canada from Outperform ➝ Sector Perform to with a price target of $11.00 ➝ $5.00.

Some recent analyst ratings include

  • 6/7/2018-Royal Bank of Canada was Downgraded by analysts at Royal Bank of Canada from a “Outperform ➝ Sector Perform” rating to a “” rating. They now have a $11.00 ➝ $5.00 price target on the stock.
  • 12/19/2017-HC Wainwright Reiterated Rating of Buy.

Recent Insider Trading Activity For NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)
NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI) has insider ownership of 19.80% and institutional ownership of 67.30%.

  • On 12/18/2017 Enterprise Associates 12 New, Major Shareholder, bought 2,000,000 with an average share price of $5.00 per share and the total transaction amounting to $10,000,000.00.
  • On 12/18/2017 Franklin M Berger, Director, bought 60,000 with an average share price of $5.00 per share and the total transaction amounting to $300,000.00.
  • On 12/18/2017 Meenu Chhabra, Insider, bought 40,000 with an average share price of $5.00 per share and the total transaction amounting to $200,000.00.
  • On 12/14/2017 Cormorant Asset Management, Ll, Major Shareholder, sold 504,027 with an average share price of $4.88 per share and the total transaction amounting to $2,459,651.76.
  • On 3/13/2017 Fmr Llc, Insider, sold 25,000 with an average share price of $12.94 per share and the total transaction amounting to $323,500.00.
  • On 3/10/2017 Fmr Llc, Insider, sold 25,000 with an average share price of $12.04 per share and the total transaction amounting to $301,000.00.
  • On 3/9/2017 Fmr Llc, Insider, sold 29,300 with an average share price of $12.08 per share and the total transaction amounting to $353,944.00.

Recent Trading Activity for NASDAQ:PTI – Proteostasis Therapeutics (NASDAQ:PTI)
Shares of NASDAQ:PTI – Proteostasis Therapeutics closed the previous trading session at 3.22 down -1.69 34.39% with 1861224 shares trading hands.